|
1
|
Tohda M, Hayashi H, Sukma M and Tanaka K:
BNIP-3: A novel candidate for an intrinsic depression-related
factor found in NG108-15 cells treated with Hochu-ekki-to, a
traditional oriental medicine, or typical antidepressants. Neurosci
Res. 62:1–8. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Caires S and Steenkamp V: Use of
Yokukansan (TJ-54) in the treatment of neurological disorders: A
review. Phytother Res. 24:1265–1270. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Onogi K, Niwa K, Tang L, Yun W, Mori H and
Tamaya T: Inhibitory effects of Hochu-ekki-to on endometrial
carcinogenesis induced by N-methyl-N-nitrosourea and
17beta-estradiol in mice. Oncol Rep. 16:1343–1348. 2006.PubMed/NCBI
|
|
4
|
Jeong JS, Ryu BH, Kim JS, Park JW, Choi WC
and Yoon SW: Bojungikki-tang for cancer-related fatigue: A pilot
randomized clinical trial. Integr Cancer Ther. 9:331–338. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Satoh H, shikawa H, Ohtsuka M and Sekizawa
K: Japanese herbal medicine in patients with advanced lung cancer:
Prolongation of survival. J Altern Complement Med. 8:107–108. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tatsumi K, Shinozuka N, Nakayama K, Sekiya
N, Kuriyama T and Fukuchi Y: Hochuekkito improves systemic
inflammation and nutritional status in elderly patients with
chronic obstructive pulmonary disease. J Am Geriatr Soc.
57:169–170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kaneko M, Kawakita T, Kumazawa Y, Takimoto
H, Nomoto K and Yoshikawa T: Accelerated recovery from
cyclophosphamide-induced leukopenia in mice administered a Japanese
ethical herbal drug, Hochu-ekki-to. Immunopharmacology. 44:223–231.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim SH, Lee SE, Oh H, Kim SR, Yee ST, Yu
YB, Byun MW and Jo SK: The radioprotective effects of
bu-zhong-yi-qi-tang: A prescription of traditional Chinese
medicine. Am J Chin Med. 30:127–137. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakayama M, Sugiyama Y, Yamasawa H, Soda
M, Mato N, Hosono T and Bando M: Effect of hochuekkito on alveolar
macrophage inflammatory responses in hyperglycemic mice.
Inflammation. 35:1294–1301. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Harada M, Seta K, Ito O, Tamada K, Li T,
Terao H, Takenoyama M, Kimura G and Nomoto K: Concomitant immunity
against tumor development is enhanced by the oral administration of
a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang).
Immunopharmacol Immunotoxicol. 17:687–703. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kuroiwa A, Liou S, Yan H, Eshita A, Naitoh
S and Nagayama A: Effect of a traditional Japanese herbal medicine,
hochu-ekki-to (Bu-Zhong-Yi-Qi Tang), on immunity in elderly
persons. Int Immunopharmacol. 4:317–324. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Utsuyama M, Seidlar H, Kitagawa M and
Hirokawa K: Immunological restoration and anti-tumor effect by
Japanese herbal medicine in aged mice. Mech Ageing Dev.
122:341–352. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsuneoka N, Tajima Y, Kitasato A, Fukuda
K, Kitajima T, Adachi T, Mishima T, Kuroki T, Onizuka S and
Kanematsu T: Chemopreventative effect of hochu-ekki-to (TJ-41) on
chemically induced biliary carcinogenesis in hamsters. J Surg Res.
151:22–27. 2009. View Article : Google Scholar
|
|
14
|
Kao ST, Yeh CC, Hsieh CC, Yang MD, Lee MR,
Liu HS and Lin JG: The Chinese medicine Bu-Zhong-Yi-Qi-Tang
inhibited proliferation of hepatoma cell lines by inducing
apoptosis via G0/G1 arrest. Life Sci. 69:1485–1496. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu K, Fukasawa I, Furuno M, Inaba F,
Yamazaki T, Kamemori T, Kousaka N, Ota Y, Hayashi M, Maehama T and
Inaba N: Inhibitory effects of herbal drugs on the growth of human
ovarian cancer cell lines through the induction of apoptosis.
Gynecol Oncol. 97:405–409. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suzuki T, Lu J, Hu G, Kita K and Suzuki N:
Retrovirus-mediated transduction of a short hairpin RNA gene for
GRP78 fails to downregulate GRP78 expression but leads to cisplatin
sensiti-zation in HeLa cells. Oncol Rep. 25:879–885. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wano C, Kita K, Takahashi S, Sugaya S,
Hino M, Hosoya H and Suzuki N: Protective role of HSP27 against
UVC-induced cell death in human cells. Exp Cell Res. 298:584–592.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Saotome K, Morita H and Umeda M:
Cytotoxicity test with simplified crystal violet staining method
using microtitre plates and its application to injection drugs.
Toxicol In Vitro. 3:317–321. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kita K, Sugita K, Chen SP, Suzuki T,
Sugaya S, Tanaka T, Jin YH, Satoh T, Tong XB and Suzuki N:
Extracellular recombinant annexin II confers UVC-radiation
resistance and increases the Bcl-xL to Bax protein ratios in human
UVC-radiation-sensitive cells. Radiat Res. 176:732–742. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sato T, Kita K, Sugaya S, Suzuki T and
Suzuki N: Extracellular release of annexin II from pancreatic
cancer cells and resistance to anticancer drug-induced apoptosis by
supplementation of recombinant annexin II. Pancreas. 41:1247–1254.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang ZB, Liu YQ and Cui YF: Pathways to
caspase activation. Cell Biol Int. 29:489–496. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Green DR and Kroemer G: The
pathophysiology of mitochondrial cell death. Science. 305:626–629.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong M, Chen SP, Kita K, Ichimura Y, Guo
WZ, Lu S, Sugaya S, Hiwasa T, Takiguchi M, Mori N, et al:
Anti-proliferative and apoptosis-inducible activity of Sarcodonin G
from Sarcodon scabrosus in HeLa cells. Int J Oncol. 34:201–207.
2009.
|
|
24
|
Haupt S, Berger M, Goldberg Z and Haupt Y:
Apoptosis-the p53 network. J Cell Sci. 116:4077–4085. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Normanno N, Maiello MR and De Luca A:
Epidermal growth factor receptor tyrosine kinase inhibitors
(EGFR-TKIs): Simple drugs with a complex mechanism of action? J
Cell Physiol. 194:13–19. 2003. View Article : Google Scholar
|
|
26
|
Ostman A and Heldin CH: PDGF receptors as
targets in tumor treatment. Adv Cancer Res. 97:247–274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Field JK and Spandidos DA: The role of ras
and myc oncogenes in human solid tumours and their relevance in
diagnosis and prognosis (review). Anticancer Res. 10:1–22.
1990.PubMed/NCBI
|
|
28
|
Slamon DJ, Clark GM, Wong SG, Levin WJ,
Ullrich A and McGuire WL: Human breast cancer: Correlation of
relapse and survival with amplification of the HER-2/neu oncogene.
Science. 235:177–182. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ogawara Y, Kishishita S, Obata T, Isazawa
Y, Suzuki T, Tanaka K, Masuyama N and Gotoh Y: Akt enhances
Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem.
277:21843–21850. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pugazhenthi S, Nesterova A, Sable C,
Heidenreich KA, Boxer LM, Heasley LE and Reusch JE: Akt/protein
kinase B up-regulates Bcl-2 expression through cAMP-response
element-binding protein. J Biol Chem. 275:10761–10766. 2000.
View Article : Google Scholar
|
|
31
|
Prokop A, Wieder T, Sturm I, Essmann F,
Seeger K, Wuchter C, Ludwig WD, Henze G, Dörken B and Daniel PT:
Relapse in childhood acute lymphoblastic leukemia is associated
with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous
caspase-3 processing in vivo. Leukemia. 14:1606–1613. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
King JC, Lu QY, Li G, Moro A, Takahashi H,
Chen M, Go VL, Reber HA, Eibl G and Hines OJ: Evidence for
activation of mutated p53 by apigenin in human pancreatic cancer.
Biochim Biophys Acta. 1823:593–604. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Redston MS, Caldas C, Seymour AB, Hruban
RH, da Costa L, Yeo CJ and Kern SE: p53 mutations in pancreatic
carcinoma and evidence of common involvement of homocopolymer
tracts in DNA microdeletions. Cancer Res. 54:3025–3033.
1994.PubMed/NCBI
|
|
34
|
Jia LQ, Osada M, Ishioka C, Gamo M, Ikawa
S, Suzuki T, Shimodaira H, Niitani T, Kudo T, Akiyama M, et al:
Screening the p53 status of human cell lines using a yeast
functional assay. Mol Carcinog. 19:243–253. 1997. View Article : Google Scholar : PubMed/NCBI
|
